옵션 체인은 다양한 행사가격과 만기일에 대한 Eyenovia의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Eyenovia에 대한 시장 심리를 평가합니다..

Eyenovia (NASDAQ:EYEN) 주식, 옵션 체인

Eyenovia

Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.

News

EYEN

FUBO

PAYX

PYCR

TSX:CSO

TSX:TD

TSXV:CSO

VSTO

블록에 신규 등장 TD 은행, 또는 토론토 도미니언 은행(TSX:TD)이 찰스 슈왑에 대한 10.1% 지분 매각을 고려 중이다. 이 매각은 이 캐나다 은행의 미국 자금 세탁 스캔들에 따른 전략적 검토의 일환이다. TD 은행의 신임 CEO인 레이먼드 천(Raymond Chun)이 블룸버그에 이 과정을 확인했다.

딜 디스패치: TD 은행이 찰스 슈왑 지분을 판매할까? 아이노비아, 스마트 쉐어가 시장에

Eyenovia Inc

<p>Technology giant, <strong>Amazon.com, Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), which reported earnings last week, remains <a href="https://www.benzinga.com/topic/amazon">one of the top holdings </a>in <strong>Dan Loeb</strong>'s Third Point LLC portfolio.</p>
<p>However, Loeb has had a complex relationship with the stock, adjusting his stake multiple times over the past <a href="https://www.sec.gov/Archives/edgar/data/1040273/000108514624005927/xslForm13F_X02/infotable.xml">two </a>years.</p>
<p><strong>Stake History</strong>: The stock entered the investor&#8217;s top list when he held <a target="_blank" href="https://www.sec.gov/Archives/edgar/data/1040273/000108514623003432/xslForm13F_X02/infotable.xml" rel="noreferrer noopener">4.1 </a>million shares in the second quarter of FY23</p>
<p>The investor then raised the stake to <a target="_blank" href="https://www.sec.gov/Archives/edgar/data/1040273/000108514623004511/xslForm13F_X02/infotable.xml" rel="noreferrer noopener">4.7 </a>million in the third quarter of FY23, followed by trimming the shares to <a target="_blank" href="https://www.sec.gov/Archives/edgar/data/1040273/000108514624001503/xslForm13F_X02/infotable.xml" rel="noreferrer noopener">4.2 </a>million in the fourth quarter of FY23 and thereafter increasing the stock holding to <a target="_blank" href="https://www.sec.gov/Archives/edgar/data/1040273/000108514624002645/xslForm13F_X02/infotable.xml" rel="noreferrer noopener">5.1 </a>million in the first quarter <a target="_blank" href="https://www.sec.gov/Archives/edgar/data/1040273/000108514624004004/xslForm13F_X02/infotable.xml" rel="noreferrer noopener">of </a>FY24.</p>
<p>Further, Loeb maintained the stake in the second quarter of FY24 but trimmed the stake to 3.7 million <a href="https://www.benzinga.com/news/large-cap/25/02/43444040/dan-loebs-third-point-trims-amazon-microsoft-meta-as-tech-stocks-climb" target="_blank" rel="noreferrer noopener">in the third quarter of FY24</a>.</p>
<p><strong>Read More: <a href="https://www.benzinga.com//node/43550696" target="_blank" rel="noreferrer noopener">Amazon To Pour Nearly&nbsp;$100 Billion&nbsp;Into AI In 2025, Surpassing Microsoft And Alphabet—Andy Jassy Says &#8216;Cost Of Inference Will Meaningfully Come Down&#8217; Amid DeepSeek Worries</a></strong></p>
<p><strong>Earnings Results</strong>: On Feb. 6, the company reported fourth-quarter net sales of $187.8 billion, up 10% year-over-year (Y/Y), which beat a Street consensus estimate of $187.3 billion and EPS of $1.86, beating a <a href="https://www.benzinga.com/25/02/43545590/amazoncom-q4-earnings-highlights-revenue-beat-eps-beat-most-successful-holiday-shopping-season-in-company-history" target="_blank" rel="noreferrer noopener">consensus estimate of $1.48</a>.</p>
<p>Amazon guided for first-quarter net sales to come in a range of $151 billion to $155.5 billion, up 5% to 9% Y/Y, which fell short <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">of the consensus of $158.5 billion</a>.</p>
<p>Amazon indicated a potential unfavorable impact of $2.1 billion due to foreign exchange rates in the first quarter. Additionally, it stated that the Leap Year could affect net sales by approximately $1.5 billion.</p>
<p>Several analysts boosted the price forecast for the company following strong fourth-quarter results, with RBC Capital<strong> </strong>analyst Brad Erickson maintaining an Outperform rating and raising the price <a target="_blank" href="https://www.benzinga.com/quote/AMZN/analyst-ratings" rel="noreferrer noopener">forecast from $255 to $265</a>.</p>
<p>Erickson said, &#8220;While the name is crowded and the AI ‘spend money to make money&#8217; debate will undoubtedly continue, the combo of AWS&#8217;s high margin growth and further network cost efficiencies have the company poised to continue growing earnings at<a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/25/02/43569359/amazon-analysts-flag-q1-guidance-concerns-ai-investment-surge" rel="noreferrer noopener"> a level supportive of this valuation,&#8221;</a>.&nbsp;</p>
<p>Meanwhile, DA Davidson analyst Gil Luria reiterated a Buy rating and upped the price forecast from $235 to $280, saying that &#8220;AWS winning in AI with better investment discipline,&#8221;.</p>
<p>Amazon's share has increased 38.02% in the last year, outperforming the&nbsp;<strong>Fidelity MSCI Consumer Discretionary Index ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDIS#NYSE">FDIS</a>), which has&nbsp;surged 24.52%, but underperformed <strong>ProShares Online Retail ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONLN#NYSE">ONLN</a>) that witnessed a growth of 43.92% over the same time frame.</p>
<p>Compared to its top peers, Amazon shares underperformed <strong>Alibaba Group Holding Limited</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), which grew 57.51%, but outperformed <strong>PDD Holdings Inc. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>), which declined 8.96% and <strong>MercadoLibre, Inc. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MELI#NASDAQ">MELI</a>), which rose 19.28% in the last one year.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/markets/equities/25/02/43649078/shopify-secures-12-of-us-e-commerce-pie-as-reebok-champion-and-warner-music-join-platform" target="_blank" rel="noreferrer noopener">Shopify Secures 12% Of US E-Commerce Pie As Reebok, Champion, And Warner Music Join Platform</a></strong></li>
</ul>
<p><em>Image created using artificial intelligence via Midjourney.</em></p>


Equities

Large Cap

AMZN

BABA

FDIS

MELI

ONLN

Citigourp Global Markets 2% Protected Notes Linked To The Djia

Dan Loeb's Amazon Stake Moves: A Look At His Trading Shifts

WIIM

RDFN

Redfin shares are trading higher after the company announced a partnership making Zillow the exclusive provider of multifamily rental listings.

<p><strong>Barrick Gold Corporation </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOLD#NYSE">GOLD</a>) shares are trading higher Wednesday after the company reported better-than-expected <a href="https://www.benzinga.com/25/02/43657514/barrick-gold-q4-higher-realized-gold-prices-lower-aisc-but-revenue-falls-short">fourth-quarter earnings</a> and announced a new $1 billion stock buyback program.</p>
<p><strong>What To Know: </strong>The company's fourth-quarter revenue came in at $3.645 billion, up 8% from the previous quarter but missing analyst estimates of $3.978 billion. Barrick reported adjusted earnings per share of 46 cents, beating Wall Street's expectation of 41 cents. </p>
<p>CEO <strong>Mark Bristow</strong> highlighted steady operational improvements across several key projects, including Pueblo Viejo, Veladero and Nevada Gold Mines. He noted that the company had made progress at Kibali while advancing major feasibility studies for the Lumwana and Reko Diq projects. Despite concerns surrounding Barrick's exposure to Mali, Bristow emphasized that the company's fundamental value remains strong.</p>
<p>Barrick also authorized a new $1 billion buyback program, replacing its previous program, which had repurchased $498 million in shares.</p>
<p>For 2025, Barrick expects gold production between 3.15 million and 3.5 million ounces, with all-in-sustaining costs projected between $1,460 and $1,560 per ounce. Capital expenditures are forecasted to be between $3.1 billion and $3.6 billion and copper production is expected to range between 200,000 and 230,000 tonnes, driven by higher output at Lumwana.</p>
<p><strong>GOLD Price Action:</strong> Barrick Gold shares were up 6.47% at $18.18 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a></p>
<p><figure class="wp-block-image size-large is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021225&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="1024" height="540" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12143534/Screenshot-2025-02-12-at-14.35.10-1024x540.png" alt="" class="wp-image-779507" style="width:500px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12143534/Screenshot-2025-02-12-at-14.35.10-1024x540.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12143534/Screenshot-2025-02-12-at-14.35.10-300x158.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12143534/Screenshot-2025-02-12-at-14.35.10-768x405.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12143534/Screenshot-2025-02-12-at-14.35.10.png 1505w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure></p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/opinion/25/02/43671549/the-perfect-stocks-portfolio-global-value-investing-in-a-changing-worldhttps://www.benzinga.com/opinion/25/02/43671549/the-perfect-stocks-portfolio-global-value-investing-in-a-changing-world">The Perfect Stocks Portfolio: Global Value Investing in a Changing World</a></strong></li>
</ul>
<p><em>Image Via Shutterstock.</em></p>


Movers

GOLD

Barrick Gold Shares Gain After Q4 Earnings And New $1 Billion Buyback Program

<p>Deep-pocketed investors have adopted a bullish approach towards Barrick Gold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOLD#NYSE">GOLD</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in GOLD usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 30 extraordinary options activities for Barrick Gold. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 46% leaning bullish and 43% bearish. Among these notable options, 8 are puts, totaling $398,820, and 22 are calls, amounting to $1,569,465.</p>
<h3>Expected Price Movements</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $13.0 and $22.0 for Barrick Gold, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Development</h3>
<p>In terms of liquidity and interest, the mean open interest for Barrick Gold options trades today is 9536.76 with a total volume of 22,863.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Barrick Gold's big money trades within a strike price range of $13.0 to $22.0 over the last 30 days.</p>
<h3>Barrick Gold Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739391332_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>GOLD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$2.43</td>
<td>$2.38</td>
<td>$2.42</td>
<td>$16.00</td>
<td>$241.2K</td>
<td>2.4K</td>
<td>1.0K</td>
</tr>
<tr>
<td>GOLD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$4.3</td>
<td>$4.2</td>
<td>$4.25</td>
<td>$15.00</td>
<td>$210.8K</td>
<td>56.7K</td>
<td>917</td>
</tr>
<tr>
<td>GOLD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$4.0</td>
<td>$3.95</td>
<td>$3.95</td>
<td>$15.00</td>
<td>$118.5K</td>
<td>1.5K</td>
<td>517</td>
</tr>
<tr>
<td>GOLD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$2.26</td>
<td>$2.13</td>
<td>$2.2</td>
<td>$16.00</td>
<td>$110.0K</td>
<td>4.9K</td>
<td>686</td>
</tr>
<tr>
<td>GOLD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$3.8</td>
<td>$3.7</td>
<td>$3.8</td>
<td>$18.00</td>
<td>$85.1K</td>
<td>881</td>
<td>338</td>
</tr>
</tbody>
</table>
</p>
<h3>About Barrick Gold</h3>
<p>Based in Toronto, Barrick Gold is one of the world's largest gold miners. In 2023, the firm produced nearly 4.1 million attributable ounces of gold and about 420 million pounds of copper. At year-end 2023, Barrick had about two decades of gold reserves along with significant copper reserves. After buying Randgold in 2019 and combining its Nevada mines in a joint venture with competitor Newmont later that year, it operates mines in 19 countries in the Americas, Africa, the Middle East, and Asia. The company also has growing copper exposure. Its potential Reko Diq project in Pakistan, if developed, could double copper production by the end of the decade.</p>
<p>Following our analysis of the options activities associated with Barrick Gold, we pivot to a closer look at the company's own performance.</p>
<h3>Present Market Standing of Barrick Gold</h3>
<ul>
<li>Trading volume stands at 31,893,320, with GOLD's price up by 6.41%, positioned at $18.16.</li>
<li>RSI indicators show the stock to be may be overbought.</li>
<li>Earnings announcement expected in 0 days.</li>
</ul>
<h3>Expert Opinions on Barrick Gold</h3>
<p>Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $18.5.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Scotiabank has revised its rating downward to Sector Perform, adjusting the price target to $19.<br />
&#x2A; An analyst from B of A Securities has revised its rating downward to Neutral, adjusting the price target to $18. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Barrick Gold, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Options

Markets

Barrick Gold Unusual Options Activity

<p>Financial giants have made a conspicuous bearish move on Baidu. Our analysis of options history for Baidu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>) revealed 85 unusual trades.</p>
<p>Delving into the details, we found 30% of traders were bullish, while 56% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $379,837, and 79 were calls, valued at $5,968,898.</p>
<h3>Projected Price Targets</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $60.0 and $170.0 for Baidu, spanning the last three months.</p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>In today's trading context, the average open interest for options of Baidu stands at 1958.74, with a total volume reaching 33,919.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Baidu, situated within the strike price corridor from $60.0 to $170.0, throughout the last 30 days.</p>
<h3>Baidu 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739391327_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>BIDU</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$10.25</td>
<td>$9.9</td>
<td>$10.0</td>
<td>$100.00</td>
<td>$998.0K</td>
<td>2.9K</td>
<td>1.0K</td>
</tr>
<tr>
<td>BIDU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$18.65</td>
<td>$18.55</td>
<td>$18.55</td>
<td>$80.00</td>
<td>$371.0K</td>
<td>1.6K</td>
<td>205</td>
</tr>
<tr>
<td>BIDU</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$27.9</td>
<td>$26.25</td>
<td>$26.6</td>
<td>$90.00</td>
<td>$266.0K</td>
<td>645</td>
<td>129</td>
</tr>
<tr>
<td>BIDU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$22.8</td>
<td>$22.2</td>
<td>$22.5</td>
<td>$85.00</td>
<td>$112.4K</td>
<td>510</td>
<td>57</td>
</tr>
<tr>
<td>BIDU</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$10.0</td>
<td>$9.45</td>
<td>$9.93</td>
<td>$90.00</td>
<td>$99.3K</td>
<td>1.2K</td>
<td>431</td>
</tr>
</tbody>
</table>
</p>
<h3>About Baidu</h3>
<p>Baidu is the largest internet search engine in China with over 50% share of the search engine market in 2024 per web analytics firm, Statcounter. The firm generated 72% of core revenue from online marketing services from its search engine in 2023. Outside its search engine, Baidu is a technology-driven company and its other major growth initiatives are artificial intelligence cloud, video streaming services, voice recognition technology, and autonomous driving.</p>
<h3>Present Market Standing of Baidu</h3>
<ul>
<li>With a trading volume of 5,480,640, the price of BIDU is up by 4.6%, reaching $93.55.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 6 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Baidu</h3>
<p>2 market experts have recently issued ratings for this stock, with a consensus target price of $112.5.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Barclays has decided to maintain their Equal-Weight rating on Baidu, which currently sits at a price target of $95.<br />
&#x2A; Reflecting concerns, an analyst from Benchmark lowers its rating to Buy with a new price target of $130.</p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Baidu, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


BIDU

Baidu Unusual Options Activity For February 12

<p>Deep-pocketed investors have adopted a bearish approach towards Amgen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in AMGN usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Amgen. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 33% leaning bullish and 66% bearish. Among these notable options, 6 are puts, totaling $210,150, and 3 are calls, amounting to $161,431.</p>
<h3>Expected Price Movements</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $280.0 to $305.0 for Amgen over the last 3 months. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>In terms of liquidity and interest, the mean open interest for Amgen options trades today is 448.17 with a total volume of 924.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Amgen's big money trades within a strike price range of $280.0 to $305.0 over the last 30 days.</p>
<h3>Amgen Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739391322_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>AMGN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$3.45</td>
<td>$3.25</td>
<td>$3.45</td>
<td>$305.00</td>
<td>$107.2K</td>
<td align="right">318</td>
<td align="right">408</td>
</tr>
<tr>
<td>AMGN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$9.0</td>
<td>$8.35</td>
<td>$9.0</td>
<td>$300.00</td>
<td>$47.7K</td>
<td align="right">344</td>
<td align="right">53</td>
</tr>
<tr>
<td>AMGN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$9.0</td>
<td>$8.95</td>
<td>$9.0</td>
<td>$300.00</td>
<td>$42.3K</td>
<td align="right">344</td>
<td align="right">100</td>
</tr>
<tr>
<td>AMGN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$13.5</td>
<td>$13.35</td>
<td>$13.5</td>
<td>$290.00</td>
<td>$33.7K</td>
<td align="right">675</td>
<td align="right">54</td>
</tr>
<tr>
<td>AMGN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$13.65</td>
<td>$13.45</td>
<td>$13.5</td>
<td>$290.00</td>
<td>$31.0K</td>
<td align="right">675</td>
<td align="right">85</td>
</tr>
</tbody>
</table>
</p>
<h3>About Amgen</h3>
<p>Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.</p>
<p>Having examined the options trading patterns of Amgen, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Present Market Standing of Amgen</h3>
<ul>
<li>With a volume of 1,356,099, the price of AMGN is down -0.63% at $294.81. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 78 days.</li>
</ul>
<h3>What Analysts Are Saying About Amgen</h3>
<p>Over the past month, 4 industry analysts have shared their insights on this stock, proposing an average target price of $305.75.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Maintaining their stance, an analyst from B of A Securities continues to hold a Underperform rating for Amgen, targeting a price of $275.<br />
&#x2A; Consistent in their evaluation, an analyst from Citigroup keeps a Neutral rating on Amgen with a target price of $295.<br />
&#x2A; An analyst from RBC Capital downgraded its action to Outperform with a price target of $324.<br />
&#x2A; An analyst from Piper Sandler persists with their Overweight rating on Amgen, maintaining a target price of $329. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Amgen with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


AMGN

Amgen Unusual Options Activity For February 12

VALE

Brazil Presidential Palace Says Vale To Announce 70 Billion Reais Investment For 2025-2030 In Copper, Iron Ore In Brazil's Carajas; Vale's Investment Announcement To Be Made At Event On Friday With Brazil's President Lula

GRAL

GRAIL shares are trading lower after the company announced the initial phase of a program to improve provider access to GRAIL's Galleri multi-cancer early detection test.

CSX Corp 13G Filing Shows JPMorgan Chase & Co. Reported A 5.5% Stake In The Co As Of December 31, 2024

<p>After a stellar 2024 and an outstanding first month of 2025, the world has again caught the gold bug. Geopolitical tensions, escalating tariff threats and fears of reappearing inflation have prompted <a href="https://www.benzinga.com/news/global/25/02/43514005/escalating-tariff-wars-tighter-african-supply-drive-gold-toward-3000-milestone">demand for physical metal</a>, causing disruptions, delays and sale suspensions.</p>
<p>South Korea is the latest country to face such a challenge. According <a href="https://www.bloomberg.com/news/articles/2025-02-12/south-korea-s-mint-halts-gold-bar-sales-as-supply-tightens">to</a> Bloomberg, the <strong>Korea Minting and Security Printing Corp</strong>, a state-owned coin issuer, has suspended sales.</p>
<p>Earlier this month, London's Gold Forward Offered Rate (GOFO) surged to 10% annually, far above the typical 2-3%. A supply shortage caused the <strong>Bank of England</strong> to announce <a href="https://in.benzinga.com/news/econ-s/25/01/43348204/gold-hits-record-high-as-central-banks-ease-stance-5-mining-stocks-rally">multi-week delivery delays</a>, prompting its gold to trade at a discount of over $5 per ounce compared to London&#8217;s spot price.</p>
<p>However, as institutions rush to move gold overseas, the logistical challenge of converting London&#8217;s 400-ounce bars into smaller, Comex-approved counterparts has added to delays. Leasing rates have also spiked to 4.7%, with central banks capitalizing on the demand by lending gold at higher premiums.</p>
<p>In 2024, these financial institutions added 1,045 tons of gold to their reserves <a href="https://www.gold.org/goldhub/research/gold-demand-trends/gold-demand-trends-full-year-2024/central-banks">per</a> World Gold Council. <strong>Barrick Gold</strong>'s CEO <strong>Mark Bristow</strong> noted that "gold is becoming reserve currency for central banks" during the leading gold miner's Q4 earnings webcast.</p>
<p>Beyond short-term supply constraints, fears of a second wave of inflation add to gold's appeal. Today's 3% CPI came in hotter than expected, marking the fourth consecutive increase in annual inflation.</p>
<p>While another wave of global inflation is not inevitable, analysts at <strong>ING Research</strong> believe that inflation will be <a href="https://www.ing.com/Newsroom/News/Inflations-second-wave-Are-we-really-watching-a-70s-rerun.htm">structurally higher</a> and more volatile within the next years. However, they acknowledge that the past is not a perfect gauge for the future, given the vastly different environment preceding the inflation period, with two recessions and oil shocks.</p>
<p>Still, the domestic economy structure also looked vastly different back then. Through the 1970s, the government ran an average yearly <a href="https://clintonwhitehouse4.archives.gov/WH/New/html/surplus2.html">budget deficit of 2.7%</a>. In 2024, the deficit was 6.4%, while the Congressional Budget Office saw it at 6.5% in 2025. To plug this hole, the government needs to sell bonds and if the Federal Reserve is the buyer, directly or through programs like Quantitative Easing, the money supply grows, usually taking inflation along.</p>
<p><strong>Read Next</strong>: <a href="https://www.benzinga.com/25/02/43651098/geopolitics-and-resource-nationalism-are-choking-the-commodity-supply">Geopolitics And Resource Nationalism Are Choking The Commodity Supply</a></p>
<p><em>Photo: Shutterstock</em></p>


Macro Economic Events

Commodities

Global

Economics

Inflation's Second-Wave Fears And Budget Deficits Support Gold's Record Pace

<p>Crypto markets are stabilizing and trending <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43667278/bitcoin-sees-short-term-volatility-after-inflation-data-altseason-remains-distant">upward after an initial drop</a> following the higher-than-expected COnsumer Price Inflation report.</p>
<p><figure class="wp-block-table"><br />
<table>
<tbody>
<tr>
<td><strong>Cryptocurrency</strong></td>
<td><strong>Price&nbsp;&nbsp;&nbsp;</strong></td>
<td><strong>Gains +/-</strong></td>
</tr>
<tr>
<td><strong>Bitcoin</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>&nbsp;$97,166.74</td>
<td>+2.2%</td>
</tr>
<tr>
<td><strong>Ethereum</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>&nbsp;$2,679.72</td>
<td>+3.4%</td>
</tr>
<tr>
<td><strong>Solana</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>&nbsp;$193.42</td>
<td>-1%</td>
</tr>
<tr>
<td><strong>XRP </strong>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>&nbsp;$2.44</td>
<td>+2.7%</td>
</tr>
<tr>
<td><strong>Dogecoin</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>&nbsp;$0.2612</td>
<td>+4.6%</td>
</tr>
<tr>
<td><strong>Shiba Inu</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>&nbsp;$0.00001680</td>
<td>+8.4%</td>
</tr>
</tbody>
</table>
<p></p></figure></p>
<p><strong>Notable Statistics:</strong></p>
<ul>
<li>IntoTheBlock data shows large transaction volume increased by 3.2% and daily active addresses grew by 2.6%. Transactions greater than $100,000 are up from 9,866 to 10,487 in a single day. Exchanges netflows are down by 192.3%.</li>
<li>Coinglass data reports 142,147 traders were liquidated in the past 24 hours for $310.39 million.</li>
<li>IntoTheBlock <a href="https://x.com/intotheblock/status/1889602444167918050">data</a> points out that the 1.6 million addresses that historically acquired 1.57 million BTC at an average price of 97,200 are now forming a resistance level. It also added that "these holders may sell near their breakeven amid market uncertainty, adding selling pressure and complicating any clear upward breakout."</li>
</ul>
<p><strong>Notable Developments:</strong></p>
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43667642/coinbase-expected-to-post-strong-earnings-as-trading-volume-hits-multi-year-high">Coinbase Expected To Post Strong Earnings As Trading Volume Hits Multi-Year High</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43646818/goldman-sachs-increases-bitcoin-etf-stake-over-1-5-billion-in-q4-reports-a-massive-1793-jump-in-ethereum-etf-holdings">Goldman Sachs Increases Bitcoin ETF Stake Over $1.5 Billion In Q4, Reports A Massive 1793% Jump In Ethereum ETF Holdings</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43658023/trump-to-nominate-ex-cftc-commissioner-brian-quintenz-as-agency-head">Trump To Nominate Ex-CFTC Commissioner Brian Quintenz As Agency Head</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43654402/el-salvador-proved-bitcoin-is-not-destined-to-be-money-analyst-says">El Salvador Proved &#8216;Bitcoin Is Not Destined To Be Money,&#8217; Analyst Says</a></li>
</ul>
<p><strong>Top Gainers:</strong></p>
<p><figure class="wp-block-table"><br />
<table>
<tbody>
<tr>
<td><strong>Cryptocurrency</strong></td>
<td><strong>Price&nbsp;&nbsp;&nbsp;</strong></td>
<td><strong>Gains +/-</strong></td>
</tr>
<tr>
<td><strong>PancakeSwap</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/cake/usd">CAKE</a>)</td>
<td>&nbsp;$2.63</td>
<td>+37.2%</td>
</tr>
<tr>
<td><strong>Sonic</strong> (CRYPTO: S)</td>
<td>&nbsp;$0.5459</td>
<td>+23.7%</td>
</tr>
<tr>
<td><strong>Onyxcoin</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">XCN</a>)</td>
<td>&nbsp;$0.02332</td>
<td>+11.3%</td>
</tr>
</tbody>
</table>
<p></p></figure></p>
<p><strong>Trader Notes: </strong>With Bitcoin prices resuming uptrend, crypto trader DonAlt predicts its Bitcoin's time to break out.</p>
<p><figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><p lang="en" dir="ltr"><a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a><br /><br />Time to break out <a href="https://t.co/NPSTi8pbh7">pic.twitter.com/NPSTi8pbh7</a></p>
<p>&mdash; DonAlt (@CryptoDonAlt) <a href="https://twitter.com/CryptoDonAlt/status/1889717070536835492?ref_src=twsrc%5Etfw">February 12, 2025</a></p></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<p></p></figure></p>
<p>Crypto Chase <a href="https://x.com/Crypto_Chase/status/1889740312215515464">explained</a> that he is still holding Bitcoin long position from $95,600 after having survived 8 days of chop and the CPI release. </p>
<p>He sees prices at local resistance, but traders are looking to take profits higher. </p>
<p>The trader moved his stop loss to around $94,000 as local liquidity was swept and demand held, making a return to the lows unlikely.</p>
<p>Crypto trader Jelle sees Bitcoin is retesting mini range and a bounce will take it back to 100,000 while Scient <a href="https://x.com/Crypto_Scient/status/1889759391647150284">highlighted</a> on Bitcoin is showing strength on a bearish news, which is a net positive outlook in the near term.</p>
<p><figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><p lang="en" dir="ltr">Retesting mini range.<br /><br />Bounce here and we charge back to $100,000 next.<a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> <a href="https://t.co/wMpCh0PKKe">pic.twitter.com/wMpCh0PKKe</a></p>
<p>&mdash; Jelle (@CryptoJelleNL) <a href="https://twitter.com/CryptoJelleNL/status/1889757090941403604?ref_src=twsrc%5Etfw">February 12, 2025</a></p></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<p></p></figure></p>
<p><strong>Read Next:&nbsp;</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43662831/bitcoin-meme-coins-dominate-crypto-but-other-projects-suffer-analyst-says">Bitcoin, Meme Coins Dominate Crypto, But Other Projects Suffer, Analyst Says</a></strong></li>
</ul>
<p><em>Image: Shutterstock</em></p>


Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$CAKE

$DOGE

$ETH

$JTO

$SHIB

$SOL

$XCN

$XRP

Bitcoin, Ethereum, XRP, Dogecoin Climb Higher As Inflation Volatility Eases: 'Don't See A Reason To Go Back To Lows,' Trader Says

<p><strong>AMC Entertainment Holdings, Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>) stock is trading higher on Wednesday after Goldman Sachs disclosed a stake <a href="https://www.benzinga.com//node/43665086">in the company</a>.</p>
<p><strong>The Details:</strong> Through a 13G filing with the Securities and Exchange Commission (SEC), Goldman revealed a 6.5% stake in AMC as of December 31. The stake is equal to roughly 24,420,283 shares.</p>
<p>Back in early December, AMC <a href="http://Back in early December, AMC entered into a sales agreement with Goldman Sachs, allowing it to sell up to 50 million Class A shares directly to the firm. AMC said it planned to use the proceeds from the agreement to strengthen its balance sheet and reinvest in its core business.">entered</a> into a sales agreement with Goldman, allowing it to sell up to 50 million Class A shares directly to the firm. The company said it planned to use the proceeds from the agreement to strengthen its balance sheet and reinvest in its core business.</p>
<p><strong>What Else:</strong> AMC is expected to release its earnings for the 2024 fiscal-year fourth-quarter on February 25. Analysts estimate a loss of 18 cents per share and revenue of $1.33 billion.</p>
<p>Ahead of earnings, Roth MKM analyst <strong>Eric Handler </strong>upgraded AMC from a Sell rating to a Neutral rating and lowered the price target from&nbsp;$4&nbsp;to&nbsp;$3.25.</p>
<p><strong>How To Buy AMC Shares</strong></p>
<p>Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. </p>
<p>For example, in AMC's case, it is in the Communication Services sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.</p>
<p><strong>Related Link: <a href="https://www.benzinga.com/insights/analyst-ratings/25/02/43670516/the-analyst-verdict-kilroy-realty-in-the-eyes-of-7-experts">The Analyst Verdict: Kilroy Realty In The Eyes Of 7 Experts</a></strong></p>
<p><strong>AMC Price Action</strong>: At the time of writing, AMC shares are trading 6.04% higher at $3.50, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro.</a></p>
<p><em>Image: via Shutterstock</em></p>


What's Going On With AMC Shares Wednesday?

<p><a href="https://x.com/Capitol_Forum/status/1889756301325996124" title="https://x.com/Capitol_Forum/status/1889756301325996124">https://x.com/Capitol_Forum/status/1889756301325996124</a></p>


OSCR

CORRECTION: Watching Oscar Health; The Capitol Forum Posts On X "Oscar Health Accused Of Misusing No Surprises Act To Delay Payments, Underpaying CA Health Systems"

<p>Curbline Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CURB#NYSE">CURB</a>) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.</p>
<p>The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $27.0, along with a high estimate of $31.00 and a low estimate of $24.00. Witnessing a positive shift, the current average has risen by 3.85% from the previous average price target of $26.00.</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739390462_0.png" alt="price target chart" /></p>
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
<p>The standing of Curbline Properties among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Alex Goldfarb</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$31.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Floris Van Dijkum</td>
<td>Compass Point</td>
<td>Raises</td>
<td>Neutral</td>
<td>$26.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Ronald Kamdem</td>
<td>Morgan Stanley</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$27.00</td>
<td>-</td>
</tr>
<tr>
<td>Floris Van Dijkum</td>
<td>Compass Point</td>
<td>Announces</td>
<td>Neutral</td>
<td>$24.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Curbline Properties. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Curbline Properties compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts gauge the dynamics of price targets, providing estimates for the future value of Curbline Properties's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Curbline Properties's market standing. Stay informed and make well-considered decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/CURB/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Curbline Properties analyst ratings.</strong></a></p>
<h2>About Curbline Properties</h2>
<p>Curbline Properties Corp is a publicly-traded REIT operating Convenience retail properties, offering enhanced access and visibility relative to other retail property types. The properties generally consist of a ubiquitous row of shop units along with dedicated parking leased to a diversified mixture of national and local service and restaurant tenants that cater to daily convenience trips from the growing suburban population.</p>
<h3>Key Indicators: Curbline Properties's Financial Health</h3>
<p><strong>Market Capitalization Analysis:</strong> Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, Curbline Properties showcased positive performance, achieving a revenue growth rate of <strong>22.92%</strong> as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Real Estate sector.</p>
<p><strong>Net Margin:</strong> Curbline Properties's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of <strong>-52.1%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Curbline Properties's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of <strong>-1.14%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Return on Assets (ROA):</strong> Curbline Properties's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of <strong>-1.1%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.03</strong>.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Analyst Ratings

CURB

Analyst Expectations For Curbline Properties's Future

<p>In the latest quarter, 4 analysts provided ratings for Staar Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STAA#NASDAQ">STAA</a>), showcasing a mix of bullish and bearish perspectives.</p>
<p>The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $23.0, a high estimate of $28.00, and a low estimate of $16.00. Observing a downward trend, the current average is 32.85% lower than the prior average price target of $34.25. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739390453_0.png" alt="price target chart" /></p>
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive Staar Surgical. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Thomas Stephan</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$20.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Mason Carrico</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$28.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Matt O'Brien</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$16.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Jon Young</td>
<td>Canaccord Genuity</td>
<td>Lowers</td>
<td>Hold</td>
<td>$28.00</td>
<td>$31.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Staar Surgical. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Staar Surgical compared to the broader market.</li>
<li><strong>Price Targets:</strong> Gaining insights, analysts provide estimates for the future value of Staar Surgical's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Staar Surgical's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/STAA/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Staar Surgical analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.</p>
<h2>All You Need to Know About Staar Surgical</h2>
<p>Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.</p>
<h3>A Deep Dive into Staar Surgical's Financials</h3>
<p><strong>Market Capitalization Analysis:</strong> Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Staar Surgical's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of <strong>10.31%</strong>. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> Staar Surgical's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>11.27%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Staar Surgical's ROE excels beyond industry benchmarks, reaching <strong>2.38%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Staar Surgical's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>1.9%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.09</strong>, Staar Surgical adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<h2>Understanding the Relevance of Analyst Ratings</h2>
<p>Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


STAA

Analyst Expectations For Staar Surgical's Future

<p>Ratings for OneStream (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OS#NASDAQ">OS</a>) were provided by 8 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.</p>
<p>The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $34.88, a high estimate of $40.00, and a low estimate of $26.00. A decline of 2.21% from the prior average price target is evident in the current average. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739390446_0.png" alt="price target chart" /></p>
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive OneStream. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Daniel Jester</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$34.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>John Difucci</td>
<td>Guggenheim</td>
<td>Maintains</td>
<td>Buy</td>
<td>$35.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Scott Berg</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$38.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Mark Murphy</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$26.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Steven Enders</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$32.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Chris Quintero</td>
<td>Morgan Stanley</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$37.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Daniel Ives</td>
<td>Wedbush</td>
<td>Announces</td>
<td>Outperform</td>
<td>$40.00</td>
<td>-</td>
</tr>
<tr>
<td>Adam Hotchkiss</td>
<td>Goldman Sachs</td>
<td>Announces</td>
<td>Buy</td>
<td>$37.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to OneStream. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of OneStream compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts provide insights into price targets, offering estimates for the future value of OneStream's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of OneStream's market position. Stay informed and make well-informed decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/OS/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on OneStream analyst ratings.</strong></a></p>
<h2>Discovering OneStream: A Closer Look</h2>
<p>OneStream Inc is an AI-enabled and extensible software platform that unifies core financial functions and broader operational data and processes within a single platform. The Digital Finance Cloud of the company provides a comprehensive, dynamic, and predictive view of the entire enterprise, providing corporate leaders the control, visibility, and agility required to proactively adjust business and day-to-day execution.</p>
<h3>Key Indicators: OneStream's Financial Health</h3>
<p><strong>Market Capitalization:</strong> Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.</p>
<p><strong>Revenue Growth:</strong> OneStream displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately <strong>20.69%</strong>. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of <strong>-133.14%,</strong> the company may need to address challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of <strong>-80.43%,</strong> the company may need to address challenges in generating satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> OneStream's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of <strong>-30.44%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Debt Management:</strong> OneStream's debt-to-equity ratio is below the industry average. With a ratio of <b>0.06</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Beyond The Numbers: 8 Analysts Discuss OneStream Stock

<p>21 analysts have shared their evaluations of Exelixis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXEL#NASDAQ">EXEL</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.</p>
<p>The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">7</td>
<td align="right">7</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">3</td>
<td align="right">6</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>In the assessment of 12-month price targets, analysts unveil insights for Exelixis, presenting an average target of $38.71, a high estimate of $45.00, and a low estimate of $29.00. Surpassing the previous average price target of $35.67, the current average has increased by 8.52%.</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739390435_0.png" alt="price target chart" /></p>
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
<p>The standing of Exelixis among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David Lebowitz</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$45.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Michael Schmidt</td>
<td>Guggenheim</td>
<td>Maintains</td>
<td>Buy</td>
<td>$42.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Sudan Loganathan</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$29.00</td>
<td>$29.00</td>
</tr>
<tr>
<td>Stephen Willey</td>
<td>Stifel</td>
<td>Raises</td>
<td>Hold</td>
<td>$36.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Joseph Catanzaro</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$38.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Ashwani Verma</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$34.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Silvan Tuerkcan</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$41.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>Asthika Goonewardene</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$43.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Sudan Loganathan</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$29.00</td>
<td>$29.00</td>
</tr>
<tr>
<td>Robert Burns</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$40.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Jefferson Harralson</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$40.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Jay Olson</td>
<td>Oppenheimer</td>
<td>Lowers</td>
<td>Perform</td>
<td>$33.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>Silvan Tuerkcan</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$41.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>Jay Olson</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$41.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Asthika Goonewardene</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$42.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Silvan Tuerkcan</td>
<td>JMP Securities</td>
<td>Raises</td>
<td>Market Outperform</td>
<td>$41.00</td>
<td>$34.00</td>
</tr>
<tr>
<td>Joseph Catanzaro</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$37.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Robert Burns</td>
<td>HC Wainwright &amp; Co.</td>
<td>Raises</td>
<td>Buy</td>
<td>$40.00</td>
<td>$29.00</td>
</tr>
<tr>
<td>Michael Schmidt</td>
<td>Guggenheim</td>
<td>Raises</td>
<td>Buy</td>
<td>$42.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Etzer Darout</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$40.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Jason Gerberry</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$39.00</td>
<td>$35.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Exelixis. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Exelixis compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts explore the dynamics of price targets, providing estimates for the future value of Exelixis's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
<p>Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Exelixis's market standing. Stay informed and make data-driven decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/EXEL/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Exelixis analyst ratings.</strong></a></p>
<h2>Unveiling the Story Behind Exelixis</h2>
<p>Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.</p>
<h3>Exelixis: Financial Performance Dissected</h3>
<p><strong>Market Capitalization:</strong> With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.</p>
<p><strong>Revenue Growth:</strong> Exelixis's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately <strong>14.33%</strong>. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.</p>
<p><strong>Net Margin:</strong> Exelixis's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>21.87%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>5.37%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Exelixis's ROA excels beyond industry benchmarks, reaching <strong>4.12%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.09</strong>.</p>
<h2>How Are Analyst Ratings Determined?</h2>
<p>Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.</p>
<p>Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


EXEL

A Glimpse Into The Expert Outlook On Exelixis Through 21 Analysts

<p>Providing a diverse range of perspectives from bullish to bearish, 12 analysts have published ratings on Fidelity National Info (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIS#NYSE">FIS</a>) in the last three months.</p>
<p>The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts have recently evaluated Fidelity National Info and provided 12-month price targets. The average target is $94.0, accompanied by a high estimate of $126.00 and a low estimate of $80.00. Experiencing a 6.0% decline, the current average is now lower than the previous average price target of $100.00. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739390427_0.png" alt="price target chart" /></p>
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
<p>A comprehensive examination of how financial experts perceive Fidelity National Info is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Timothy Chiodo</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$81.00</td>
<td>$94.00</td>
</tr>
<tr>
<td>Daniel Perlin</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$95.00</td>
<td>$104.00</td>
</tr>
<tr>
<td>Andrew Bauch</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$80.00</td>
<td>$88.00</td>
</tr>
<tr>
<td>James Friedman</td>
<td>Susquehanna</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$81.00</td>
<td>$103.00</td>
</tr>
<tr>
<td>Charles Nabhan</td>
<td>Stephens &amp; Co.</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$90.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Dominick Gabriele</td>
<td>Compass Point</td>
<td>Lowers</td>
<td>Buy</td>
<td>$113.00</td>
<td>$126.00</td>
</tr>
<tr>
<td>James Faucette</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$86.00</td>
<td>$92.00</td>
</tr>
<tr>
<td>Vasundhara Govil</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$92.00</td>
<td>$102.00</td>
</tr>
<tr>
<td>Daniel Perlin</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$104.00</td>
<td>$104.00</td>
</tr>
<tr>
<td>Andrew Bauch</td>
<td>Wells Fargo</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$88.00</td>
<td>-</td>
</tr>
<tr>
<td>James Faucette</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$92.00</td>
<td>$87.00</td>
</tr>
<tr>
<td>Dominick Gabriele</td>
<td>Compass Point</td>
<td>Announces</td>
<td>Buy</td>
<td>$126.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Fidelity National Info. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Fidelity National Info compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
<p>Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Fidelity National Info's market standing. Stay informed and make data-driven decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/FIS/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Fidelity National Info analyst ratings.</strong></a></p>
<h2>About Fidelity National Info</h2>
<p>Fidelity National Information Services provides core processing and ancillary services to banks, but its business has expanded over time. By acquiring SunGard in 2015, the company now provides record-keeping and other services to investment firms. With the acquisition of Worldpay in 2019, FIS was providing payment processing services for merchants and holding leading positions in the United States and United Kingdom. But the company sold off a majority interest in Worldpay and now has only a minority stake.</p>
<h3>Fidelity National Info's Economic Impact: An Analysis</h3>
<p><strong>Market Capitalization Analysis:</strong> The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, Fidelity National Info showcased positive performance, achieving a revenue growth rate of <strong>3.13%</strong> as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of <strong>8.72%,</strong> the company may need to address challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Fidelity National Info's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of <strong>1.33%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Fidelity National Info's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of <strong>0.65%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.66</strong>, Fidelity National Info adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p>If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


A Glimpse Into The Expert Outlook On Fidelity National Info Through 12 Analysts

<p><strong>AMETEK's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) short percent of float has fallen 7.69% since its last report. The company recently reported that it has <strong>1.97 million shares sold short</strong>, which is 0.96% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 1.28 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest"><strong>List of the most shorted stocks</strong></a></p>
<h3>AMETEK Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739390424_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for AMETEK has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.</p>
<h3>Comparing AMETEK's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, AMETEK's peer group average for short interest as a percentage of float is 10.42%, which means the company has <strong>less</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Short Sellers

Short Ideas

Trading Ideas

Looking Into AMETEK's Recent Short Interest

<p><strong>Carpenter Tech's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRS#NYSE">CRS</a>) short percent of float has risen 11.25% since its last report. The company recently reported that it has <strong>2.79 million shares sold short</strong>, which is 7.81% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 3.42 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest"><strong>List of the most shorted stocks</strong></a></p>
<h3>Carpenter Tech Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739390418_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Carpenter Tech has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.</p>
<h3>Comparing Carpenter Tech's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Carpenter Tech's peer group average for short interest as a percentage of float is 4.85%, which means the company has <strong>more</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Looking Into Carpenter Tech's Recent Short Interest

Eyenovia (EYEN) announced that it has entered into a securities purchase agreement with a healthcare focused institutional investor for the purchas...

Eyenovia announces pricing of $1.9M registered direct offering

The latest update is out from Eyenovia ( ($EYEN) ). Eyenovia, Inc. has announced a $1.9 million registered direct offering, selling common stock an...

Eyenovia's $1.9M Offering to Boost Optejet Development

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include:&nbsp...

Biotech Alert: Searches spiking for these stocks today

Eyenovia (EYEN) announced that the two leading independent proxy advisory firms, Institutional Shareholder Services and Glass Lewis & Co., have rec...

Eyenovia announces advisory firms recommend vote 'FOR' reverse stock split

Eyenovia (EYEN) announced that its board of directors approved a 1-for-80 reverse stock split of its outstanding shares of common stock, $0.0001 pa...

Eyenovia announces 1-for-80 reverse stock split

Eyenovia approves 1-for-80 reverse stock split; shares slip

19:50 EST Eyenovia (EYEN) trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking financ...

Eyenovia trading halted, news pending

These are the upcoming stock splits for the week of February 3 to February 7, based on&nbsp;TipRanks' Stock Splits Calendar. A&nbsp;stock split&nbs...

Upcoming Stock Splits This Week (February 3 to February 7) – Stay Invested

Eyenovia (EYEN) announces recent progress on the development of its user-filled spray dispenser. "Millions of consumers have difficulty with tradit...

Eyenovia announces progress on next-gen user-filled Optejet

ACSAY

ANAB

AUPH

BGNE

CDTX

CLRB

CMRX

GCTK

JAGX

MIST

MRNS

PGEN

QURE

RCKT

SGMO

VSTM

XFOR

Press Releases

Eyenovia to Report Third Quarter 2024 Results on Tuesday, November 12th

Earnings

Eyenovia Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Health Care

Eyenovia Provides Update on Phase 3 CHAPERONE Study

Eyenovia Provides Update on Restructuring Efforts

Eyenovia, Inc. Announces Pricing of $1.3 Million Registered Direct Offering

Financing

Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering

General

Eyenovia Engages Chardan as Advisor for Review of Strategic Alternatives

Eyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote "FOR" Proposed Reverse Stock Split at Upcoming Special Meeting of Stockholders

Comments

Eyenovia

Eyenovia (EYEN) 옵션

Eyenovia (NASDAQ:EYEN) 주식, 옵션 체인

뉴스

파트너 / 기고자

벤징가 글로벌